| Zurich Market Talk - 17-10-2011 |
| 17.10.11 07:20 | |
|
Kuehne + Nagel: Stable results despite softening market environment. In the first nine months 2011, the worldwide operating Kuehne + Nagel Group delivered stable results despite divergent economic conditions and slowing market growth. Net earnings improved by 1.1 per cent (currency adjusted: by 15.6 per cent) to CHF 454 million. At CHF 728 million the operational result (EBITDA) was 2.4 per cent below (currency adjusted: 11.5 per cent above) the figure of the previous year’s period. Turnover decreased by 3.8 per cent (currency adjusted: increased by 10.1 per cent) to CHF 14,598 million. Link: Click Here Implenia now visible in the far north - Betonmast Anlegg is to operate on the Norwegian market under the Implenia brand. Implenia’s daisy logo will be on show in the far north too from next Monday. The Norwegian tunnel and infrastructure specialist Betonmast Anlegg, acquired on 18 July, will from now on operate in the Norwegian market as Implenia. Link: Click Here Roche (SIX: RO, ROG) and Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) today announced that the two companies have entered into a definitive merger agreement for Roche to fully acquire Anadys at a price of USD3.70 per share in an all-cash transaction. This corresponds to a total cash consideration of approximately USD 230 million. Link: Click Here |
| < Prev | Next > |
|---|